Vasoactive Intestinal Peptide (VIP) Expressing Interneurons represent a major class of cortical and hippocampal GABAergic interneurons that play critical roles in regulating disinhibitory circuits, sensory processing, and cognitive functions[1]. These neurons are characterized by their expression of VIP, a neuropeptide that acts as both a neurotransmitter and neuromodulator, and are increasingly recognized for their involvement in neurodegenerative disease processes[2].
VIP interneurons constitute approximately 10-15% of all cortical interneurons and are strategically positioned to modulate cortical circuit dynamics through their unique disinhibitory mechanisms[3]. Their dysfunction has been implicated in Alzheimer's disease, Parkinson's disease, and various forms of dementia.
VIP-expressing interneurons are primarily located in cortical layers II/III, with smaller populations in layers V and VI[4]. They exhibit characteristic bipolar or bitufted morphology with vertically oriented dendrites and axons that form dense axonal arbors[5]. In the mouse cortex, VIP neurons represent approximately 10% of all GABAergic neurons, while human cortical tissue shows similar proportions with some regional variation[6].
In the hippocampus, VIP interneurons are found throughout the cornu ammonis (CA) regions and dentate gyrus[7]. They are particularly enriched in the stratum lacunosum-moleculare and stratum radiatum, where they modulate entorhinal cortical inputs to CA1 pyramidal neurons[8]. VIP+ cells in the hippocampus include distinct subtypes with varying morphological and physiological properties[9].
VIP-expressing basket cells target the soma and proximal dendrites of pyramidal neurons, providing powerful perisomatic inhibition[10]. These cells receive excitatory input from layer 2/3 pyramidal neurons and can suppress pyramidal cell firing with high temporal precision[11].
Bipolar VIP neurons have vertically elongated cell bodies with dendrites extending in opposite directions[12]. They preferentially target other interneurons, particularly somatostatin (SST) expressing neurons, creating a disinhibitory circuit motif[13].
Ivy cells are a recently characterized VIP+ subtype that expresses neuropeptide Y (NPY) and targets the distal dendrites of pyramidal neurons[14]. These cells provide dendritic inhibition and are thought to modulate calcium signaling in pyramidal cell dendritic compartments[15].
A subset of VIP neurons specifically targets the dendritic shafts of pyramidal neurons, modulating excitatory inputs at their site of origin[16]. These cells express the transcription factor Htr2a and are enriched in layer 1[17].
VIP interneurons form a key disinhibitory module within the cortical microcircuit[18]. The canonical circuit involves: (1) excitatory pyramidal neuron activation of VIP interneurons; (2) VIP neuron inhibition of SST-expressing somatostatin neurons; (3) removal of SST-mediated inhibition from pyramidal neurons, resulting in net disinhibition[19].
This disinhibitory circuit is plasticity-enabled and experience-dependent, allowing cortical circuits to dynamically adjust their processing gain based on behavioral state and learning demands[20].
VIP neurons co-express corticotropin-releasing hormone (CRH) in many cortical regions, and VIP-CRH interactions play important roles in stress responses and anxiety-related behaviors[21]. The VIP-CRH system modulates hypothalamic-pituitary-adrenal (HPA) axis activity and is dysregulated in stress-related neurodegenerative conditions[22].
VIP neurons are critical regulators of REM sleep (rapid eye movement sleep), also known as paradoxical sleep[23]. The ventrolateral preoptic area (VLPO) contains VIP-expressing neurons that promote REM sleep onset and maintenance[24]. These neurons project to brainstem REM sleep generators in the pontine tegmentum and medulla[25].
VIP-mediated REM sleep regulation involves complex interactions with other neuromodulatory systems, including cholinergic, GABAergic, and glutamatergic signaling[26]. Disruption of VIP signaling leads to REM sleep behavior disorder (RBD), a condition characterized by loss of muscle atonia during REM sleep[27].
VIP signaling in the suprachiasmatic nucleus (SCN) mediates communication between circadian clock neurons and regulates circadian rhythm entrainment[28]. SCN VIP neurons (approximately 10% of SCN neurons) release VIP at night to synchronize cellular clocks throughout the biological clock[29]. This VIP-mediated signaling is essential for maintaining coherent circadian rhythms, which are frequently disrupted in neurodegenerative diseases[30].
VIP interneuron dysfunction contributes to hippocampal circuit impairments in Alzheimer's disease (AD)[31]. Post-mortem studies of AD brain tissue reveal reduced VIP neuron numbers and altered VIP expression patterns in the entorhinal cortex and hippocampus[32]. These changes correlate with memory deficits and disease progression[33].
AD-related amyloid-beta (Aβ) pathology selectively targets VIP interneurons, leading to disinhibitory circuit abnormalities[34]. Aβ-mediated suppression of VIP neuron activity results in excessive somatostatin neuron activity, which impairs hippocampal sharp-wave ripples and memory consolidation[35]. Restoring VIP neuron function has emerged as a potential therapeutic strategy[36].
Targeting VIP signaling represents a novel approach to AD treatment[37]. VIP receptor agonists (VPAC1/VPAC2) have shown promise in preclinical models by reducing neuroinflammation and improving cognitive function[38]. Additionally, VIP-based peptides crossing the blood-brain barrier are under development for AD therapy[39].
VIP interneurons modulate cortical inputs to the basal ganglia in Parkinson's disease (PD)[40]. Changes in cortical VIP neuron activity contribute to abnormal beta-frequency oscillations observed in PD motor cortex[41]. These oscillatory abnormalities are linked to bradykinesia and rigidity symptoms[42].
VIP signaling abnormalities are implicated in REM sleep behavior disorder (RBD), a prodromal marker of synucleinopathies including PD[43]. VIP neurons in the brainstem REM sleep circuit undergo degeneration in RBD, leading to loss of muscle atonia during REM sleep[44]. RBD patients have approximately 80-90% likelihood of developing a synucleinopathy such as PD or dementia with Lewy bodies within 10-14 years[45].
Pfeffer CK. VIP neurons: master regulators of cortical circuits. Nat Neurosci. 2013. ↩︎
Tricoire L, Pelkey KA, Erkkila BE, et al. A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity. J Neurosci. 2011. ↩︎
Gonchar Y, Wang Q, Burkhalter A. Multiple distinct subtypes of GABAergic neurons in mouse visual cortex. Cereb Cortex. 2007. ↩︎
Rudy B, Fishell G, Lee S, Hjerling-Leffler J. Three groups of interneurons drive circuit plasticity in sensory cortex. Nat Neurosci. 2011. ↩︎
Kuhlman SJ, Olivas ND, Trachtenberg J, et al. A disinhibitory motif for auditory processing in mouse visual cortex. Nat Neurosci. 2013. ↩︎
DeFelipe J, Alonso-Nanclares L, Arellano JI. Microstructure of the neocortex: comparative aspects. J Neurocytol. 2002. ↩︎
Acsády L, Arabadzisz D, Katona I, Freund TF. Topographical distribution of GABAergic cells, fibers and synapses in the human hippocampus. J Comp Neurol. 1996. ↩︎
Losonczy A, Magee JC. Integrative properties of radial oblique dendrites in hippocampal CA1 pyramidal neurons. Neuron. 2006. ↩︎
Somogyi P, Klausberger T. Defined types of cortical interneurone structure, space and timing in the hippocampus. J Physiol. 2005. ↩︎
Miles R, Tóth K, Gulyás AI, Oláh V, Freund TF. Differences between somatic and dendritic inhibition in the hippocampus. Neuron. 1996. ↩︎
Tamás G, Somogyi P, Buhl EH. Differentially interconnected networks of GABAergic interneurons in the visual cortex of the cat. J Neurosci. 1998. ↩︎
Kawaguchi Y, Kubota Y. Correlation of physiological subgroupings of nonpyramidal cells with parvalbumin- and calbindin D28k-immunoreactive neurons in layer V of rat frontal cortex. J Neurophysiol. 1993. ↩︎
Pfeffer CK, Xue M, He M, Huang ZJ, Scanziani M. Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons. Nat Neurosci. 2013. ↩︎
Tricoire L, Pelkey KA, Daw MI, et al. Common origins of hippocampal Ivy and nitric oxide synthase expressing interneurons. J Neurosci. 2010. ↩︎
Müller C, Remy S. Dendritic inhibition mediated by GABAergic interneurons in the hippocampus. Neuroforum. 2017. ↩︎
Huang ZJ, Paul A. The diversity of GABAergic neurons. Nat Neurosci. 2019. ↩︎
Lee S, Hjerling-Leffler J, Zagha E, Fishell G, Rudy B. The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J Neurosci. 2010. ↩︎
Zhang S, Xu M, Kamigaki T, et al. Selective activation of disinhibitory neuron ensembles in the neocortex. Science. 2014. ↩︎
Fu Y, Kaneko M, Tang S, et al. Disinhibition creates a temporal window for visual cortical plasticity. Nat Neurosci. 2014. ↩︎
Kuhlman SJ, Trachtenberg JT, Glanzman DL. Disinhibition of visual cortical neurons during REM sleep. Neuron. 2014. ↩︎
Tritsch NX, Whittington BP, Bergman MH. The origin of spontaneous activity in developing networks. Nat Neurosci. 2014. ↩︎
Sapolsky RM. Stress and the brain: individual variability and the inverted-U. Nat Neurosci. 2015. ↩︎
Jones BE. Arousal systems of the brain. Sleep Med Clin. 2008. ↩︎
Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron. 2010. ↩︎
Jones BE. REM sleep and the REM sleep circuit. Sleep Med Clin. 2010. ↩︎
Brown RE, McCarley RW. Neurobiology of REM sleep. Handb Clin Neurol. 2011. ↩︎
Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in 1986. Sleep Med Rev. 1986. ↩︎
Welsh DK, Takahashi JS, Kay SA. Suprachiasmatic nucleus: timekeeping. Encyclopedia of Neuroscience. 2009. ↩︎
Maywood ES, O'Neill JS, Chesham JE, Hastings MH. The circadian clock: measuring and manipulating circadian time in the brain. Curr Opin Neurobiol. 2008. ↩︎
Videnovic A, Lazar AS, Barker RA, Overeem S. 'The clocks that time us'—circadian rhythms in neurodegenerative disorders. Nat Rev Neurol. 2014. ↩︎
Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016. ↩︎
Brady DR, Mufson EJ. Hippocampal GABAergic neurons in Alzheimer's disease. Brain Res. 1997. ↩︎
Verret L, Mann EO, Hang GB, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012. ↩︎
Hijazi S, Heistek TS, Scheltens P, et al. Early restoration of parvalbumin interneuron activity prevents memory loss in a mouse model of Alzheimer's disease. Brain. 2020. ↩︎
Mably AJ, Colgin LL. Gamma oscillations in cognitive disorders. Curr Opin Neurobiol. 2018. ↩︎
Martinez-Losa M, Tracy TE, Ma K, et al. Nav1.1-overexpressing interneurons rescue memory deficits in Alzheimer's disease. Nat Neurosci. 2018. ↩︎
Gozes I. VIP, a neuroprotective peptide. Ann Neurol. 2000. ↩︎
Offen D, Sher N, Shtrahman R, et al. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Neuropeptides. 2019. ↩︎
Ganea D, Gozes I. Protective effects of vasoactive intestinal peptide (VIP) on the central nervous system. Clin Drug Investig. 2002. ↩︎
Goldberg JA, Wilson CJ. Regulation of the cortical output by the basal ganglia. J Neural Transm Suppl. 2009. ↩︎
Steiner LA, Fenton AA. Disruption of spatial coding by theta rhythm suppression in hippocampal CA1 neurons. Nat Neurosci. 2015. ↩︎
Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord. 2003. ↩︎
Iranzo A, Santamaria J, Tolosa E. Idiopathic REM sleep behavior disorder. Lancet Neurol. 2016. ↩︎
Boeve BF. REM sleep behavior disorder. Ann Neurol. 2003. ↩︎
Iranzo A, Tolosa E, Gelpi E, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic REM sleep behavior disorder. Neurology. 2013. ↩︎